Injecting functional adenosine deaminase into a patient's (lacking $ADA$ gene) blood cells may be considered as

  • A
    Gene therapy
  • B
    Enzyme replacement therapy
  • C
    Both $(a)$ and $(b)$
  • D
    Genetic engineering

Explore More

Similar Questions

How is a mature,functional insulin hormone different from its prohormone form?

What is absent in mature insulin?

Consult internet and find out how to make orally active protein pharmaceutical. What is the major problem to be encountered?

$ELISA$ is used to detect viruses,where:

The use of living organisms for human welfare is called......

Vedclass Products

For Students

Vedclass Test Series

Mock tests in real JEE/NEET style with performance analysis. 5-day free trial.

Start Free Trial
For Teachers

Exam Paper Generator

Generate Set A/B/C/D exam papers from 7.5L+ questions in 2 minutes. 3 chapters free.

Try Free
For Institutes

Online Exam Module

Live online exams with unlimited students, 360° analytics & white-label branding.

See Demo